A simple, new five-question survey may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD), states study. Researchers from David Geffen School of Medicine at UCLA, Olmsted Medical Center, Boehringer-Ingelheim Pharmaceuticals Inc , and Pfizer Inc, randomized 9,704 patients with no prior COPD diagnosis from US primary care practices in seven states into three groups based on treatment Arm 1: COPD-PS plus spirometry; Arm 2: COPD-PS alone; ...Monday, 22 October 2012
Simple Survey may Increase COPD Diagnoses
A simple, new five-question survey may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD), states study. Researchers from David Geffen School of Medicine at UCLA, Olmsted Medical Center, Boehringer-Ingelheim Pharmaceuticals Inc , and Pfizer Inc, randomized 9,704 patients with no prior COPD diagnosis from US primary care practices in seven states into three groups based on treatment Arm 1: COPD-PS plus spirometry; Arm 2: COPD-PS alone; ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment